Salter Malcolm
SEC CIK 1825124 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | Dir | 11.4K | — | $183.7K | 9 | 2021-07-02 | 2022-01-04 |
Most active insiders at CCCC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | REYNO LEONARD | Chief Medical Off | — | $22.2K |
| 2 | Mahaney Paige | CSO | — | — |
| 3 | Mossler Mark | CAO | — | — |
| 4 | Adams Kendra | CFO | — | — |
| 5 | Boyle Scott N | Chief Business Off | — | — |
| 6 | Anderson Kenneth Carl | Dir | — | — |
| 7 | Schick Kelly | CHRO | — | — |
| 8 | GROGAN DONNA ROY | Dir | — | — |
| 9 | Hirsch Andrew | Pres, CEO, Dir | — | — |
Salter Malcolm made no open-market trades at CCCC in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-18 | 2022-01-04 | CCCC | C4 Therapeutics, Inc. | Salter Malcolm | Dir | A - Grant | $31.58 | +428 | 11.4K | +4% | +$13.5K | |
| 2021-12-17 | 2021-12-17 | CCCC | C4 Therapeutics, Inc. | Salter Malcolm | Dir | S - Sale | $30.25 | -755 | 11.0K | -6% | -$22.8K | |
| 2021-11-19 | 2021-11-19 | CCCC | C4 Therapeutics, Inc. | Salter Malcolm | Dir | S - Sale | $40.11 | -755 | 11.7K | -6% | -$30.3K | |
| 2021-10-15 | 2021-10-15 | CCCC | C4 Therapeutics, Inc. | Salter Malcolm | Dir | S - Sale | $44.94 | -755 | 12.5K | -6% | -$33.9K | |
| 2021-10-05 | 2021-10-04 | CCCC | C4 Therapeutics, Inc. | Salter Malcolm | Dir | A - Grant | $44.99 | +300 | 13.2K | +2% | +$13.5K | |
| 2021-09-21 | 2021-09-17 | CCCC | C4 Therapeutics, Inc. | Salter Malcolm | Dir | S - Sale | $49.89 | -755 | 12.9K | -6% | -$37.7K | |
| 2021-08-24 | 2021-08-20 | CCCC | C4 Therapeutics, Inc. | Salter Malcolm | Dir | S - Sale | $40.73 | -755 | 13.7K | -5% | -$30.8K | |
| 2021-07-19 | 2021-07-16 | CCCC | C4 Therapeutics, Inc. | Salter Malcolm | Dir | S - Sale | $37.37 | -755 | 14.4K | -5% | -$28.2K | |
| 2021-07-07 | 2021-07-02 | CCCC | C4 Therapeutics, Inc. | Salter Malcolm | Dir | A - Grant | $39.72 | +339 | 15.2K | +2% | +$13.5K |
Purchase Sale Sale after option exercise All abbreviations